Log in

NASDAQ:OBSVObseva Stock Price, Forecast & News

$2.66
-0.03 (-1.12 %)
(As of 08/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.65
Now: $2.66
$2.73
50-Day Range
$2.54
MA: $3.84
$6.15
52-Week Range
$1.63
Now: $2.66
$10.35
Volume427,759 shs
Average Volume828,368 shs
Market Capitalization$129.19 million
P/E RatioN/A
Dividend YieldN/A
Beta0.78
ObsEva SA, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women; Nolasiban, an oral oxytocin receptor antagonist to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization; and OBE022, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age. The company was founded in 2012 and is headquartered in Plan-les-Ouates, Switzerland.
Read More
Obseva logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.3Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.64 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:OBSV
CUSIPN/A
Phone41-22-552-3840

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$1.01 per share

Profitability

Net Income$-108,790,000.00

Miscellaneous

Employees43
Market Cap$129.19 million
Next Earnings DateN/A
OptionableNot Optionable
$2.66
-0.03 (-1.12 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OBSV News and Ratings via Email

Sign-up to receive the latest news and ratings for OBSV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Obseva (NASDAQ:OBSV) Frequently Asked Questions

How has Obseva's stock been impacted by COVID-19 (Coronavirus)?

Obseva's stock was trading at $2.57 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, OBSV shares have increased by 3.5% and is now trading at $2.66.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Obseva?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Obseva in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Obseva
.

How were Obseva's earnings last quarter?

Obseva SA (NASDAQ:OBSV) announced its quarterly earnings data on Thursday, August, 6th. The company reported ($0.38) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.42) by $0.04.
View Obseva's earnings history
.

What price target have analysts set for OBSV?

7 brokers have issued 1-year price objectives for Obseva's shares. Their forecasts range from $4.00 to $36.00. On average, they anticipate Obseva's share price to reach $14.71 in the next year. This suggests a possible upside of 453.2% from the stock's current price.
View analysts' price targets for Obseva
.

Has Obseva been receiving favorable news coverage?

Media coverage about OBSV stock has trended very positive this week, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Obseva earned a news impact score of 4.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days.
View the latest news about Obseva
.

Are investors shorting Obseva?

Obseva saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 1,780,000 shares, an increase of 159.6% from the June 30th total of 685,800 shares. Based on an average daily trading volume, of 1,120,000 shares, the days-to-cover ratio is presently 1.6 days. Approximately 6.0% of the shares of the company are short sold.
View Obseva's Current Options Chain
.

Who are some of Obseva's key competitors?

What other stocks do shareholders of Obseva own?

Who are Obseva's key executives?

Obseva's management team includes the following people:
  • Dr. Ernest Loumaye, Co-Founder, CEO & Director (Age 67)
  • Mr. Timothy M. Adams, Chief Financial Officer (Age 59)
  • Dr. Jean-Pierre Gotteland Ph.D., Chief Scientific Officer and Head of R&D (Age 54)
  • Mr. Mario Vincent Corso, Sr. Director of Investor Relations
  • Dr. Elke Bestel M.D., Chief Medical Officer & Head of Pharmacovigilance (Age 53)

When did Obseva IPO?

(OBSV) raised $98 million in an initial public offering on Thursday, January 26th 2017. The company issued 6,500,000 shares at $14.00-$16.00 per share. Credit Suisse, Jefferies and Leerink Partners acted as the underwriters for the IPO.

What is Obseva's stock symbol?

Obseva trades on the NASDAQ under the ticker symbol "OBSV."

Who are Obseva's major shareholders?

Obseva's stock is owned by a variety of institutional and retail investors. Top institutional investors include Zurcher Kantonalbank Zurich Cantonalbank (0.40%), Wedbush Securities Inc. (0.31%) and Virtu Financial LLC (0.10%).

Which institutional investors are buying Obseva stock?

OBSV stock was acquired by a variety of institutional investors in the last quarter, including Virtu Financial LLC, Zurcher Kantonalbank Zurich Cantonalbank, and Wedbush Securities Inc..

How do I buy shares of Obseva?

Shares of OBSV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Obseva's stock price today?

One share of OBSV stock can currently be purchased for approximately $2.66.

How big of a company is Obseva?

Obseva has a market capitalization of $129.19 million. The company earns $-108,790,000.00 in net income (profit) each year or ($2.49) on an earnings per share basis. Obseva employs 43 workers across the globe.

What is Obseva's official website?

The official website for Obseva is www.obseva.com.

How can I contact Obseva?

Obseva's mailing address is Chemin des Aulx 12 Plan-les-Ouates, Geneva V8, 1228. The company can be reached via phone at 41-22-552-3840 or via email at [email protected]

This page was last updated on 8/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.